Shtein Roni M, Hussain Munira T, Cooney Theresa M, Elner Victor M, Hood Christopher T
From the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA.
From the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA.
J Cataract Refract Surg. 2014 May;40(5):793-8. doi: 10.1016/j.jcrs.2013.10.031. Epub 2014 Mar 14.
To determine whether preoperative iris vasculature and morphology are altered in patients who have taken tamsulosin (Flomax).
Academic multispecialty practice.
Case series.
Patients with current or past tamsulosin use and age- and sex-matched control patients were included. Anterior segment optical coherence tomography (AS-OCT) and iris fluorescein angiography were performed to measure iris vasculature and thickness before cataract surgery. Data collected at surgery included pupil diameter, clinical signs of intraoperative floppy-iris syndrome, and surgical complications.
Tamsulosin was currently used by 16 patients and in the past by 4 patients; the control group comprised 10 patients. Pharmacologically dilated pupil diameter was statistically significantly smaller preoperatively and immediately postoperatively in the tamsulosin group than in the control group (P=.009 and P=.003, respectively). There was a statistically significant decrease in pupil size intraoperatively in the tamsulosin group (P=.05) but not in the control group (P=.3). Iris-vasculature parameters, specifically time to first vessel fill and percentage of vessel fill on iris fluorescein angiography, were not significantly different between the 2 groups. The AS-OCT measurements of iris morphology were not statistically significantly different between the groups. No surgical complications occurred. No fluorescein dye leakage, staining, or other vascular anomalies were observed.
Although there were differences in pupil measurements and intraoperative iris behavior between patients who had been on tamsulosin and control patients, there were no significant differences in iris vasculature on iris fluorescein angiography or in iris morphology on AS-OCT.
确定服用坦索罗辛(哈乐)的患者术前虹膜血管系统和形态是否发生改变。
学术性多专科医疗机构。
病例系列研究。
纳入正在使用或既往使用过坦索罗辛的患者以及年龄和性别匹配的对照患者。在白内障手术前,采用眼前节光学相干断层扫描(AS-OCT)和虹膜荧光血管造影术测量虹膜血管系统和厚度。手术中收集的数据包括瞳孔直径、术中虹膜松弛综合征的临床体征和手术并发症。
16例患者目前正在使用坦索罗辛,4例患者既往使用过;对照组有10例患者。坦索罗辛组术前和术后即刻经药物散瞳后的瞳孔直径在统计学上显著小于对照组(分别为P = 0.009和P = 0.003)。坦索罗辛组术中瞳孔大小有统计学意义的减小(P = 0.05),而对照组无(P = 0.3)。两组间虹膜血管系统参数,特别是虹膜荧光血管造影上首次血管充盈时间和血管充盈百分比,差异无统计学意义。两组间AS-OCT测量的虹膜形态差异无统计学意义。未发生手术并发症。未观察到荧光素染料渗漏、染色或其他血管异常。
虽然服用坦索罗辛的患者与对照患者在瞳孔测量和术中虹膜表现上存在差异,但在虹膜荧光血管造影的虹膜血管系统或AS-OCT的虹膜形态方面无显著差异。